Search Results - Alejandra Castanon

RWE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 16 by Alejandra Castanon, Antonia Tsvetanova, Sreeram V Ramagopalan

Connect to this object online.

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 15 by Alejandra Castanon, Benjamin D Bray, Sreeram V Ramagopalan

Connect to this object online.

Why is target trial emulation not being used in health technology assessment real-world data submissions? by Alejandra Castanon, Stephen Duffield, Sreeram Ramagopalan, Robert Reynolds

Connect to this object online.

EU HTA Joint Clinical Assessment: are patients with rare disease going to lose out? by Alejandra Castanon, Rebecca Sloan, Luisamanda Selle Arocha, Sreeram V Ramagopalan

Connect to this object online.

Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study by Alejandra Castanon, MD, Rebecca Landy, PhD, Francesca Pesola, PhD, Peter Windridge, PhD, Prof Peter Sasieni, PhD

Connect to this object online.

The impact of the COVID-19 pandemic on cardiovascular disease prevention and corresponding geographical inequalities in England: interrupted time series analysis by Alejandra Castanon, Katja Grasic, Simon Chen, Florence Ma, Godspower Oboli, Benjamin D. Bray, Andrew Hughes, Martin White, Shahed Ahmad, Jonathan Pearson-Stuttard

Connect to this object online.